clinical trials

Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials
Pieter Hindryckx, Barrett G Levesque, Tom Holvoet, Serina Durand, Ceen-Ming Tang, Claire Parker, Reena Khanna, Lisa M Shackelton, Geert D'Haens, William J Sandborn, Brian G Feagan, Benjamin Lebwohl, Daniel A Leffler, Vipul Jairath

Gut Jan 2018, 67 (1) 61-69; DOI: 10.1136/gutjnl-2016-312762
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study
Tania M Welzel, David R Nelson, Giuseppe Morelli, Adrian Di Bisceglie, Rajender K Reddy, Alexander Kuo, Joseph K Lim, Jama Darling, Paul Pockros, Joseph S Galati, Lynn M Frazier, Saleh Alqahtani, Mark S Sulkowski, Monika Vainorius, Lucy Akushevich, Michael W Fried, Stefan Zeuzem

Gut Oct 2017, 66 (10) 1844-1852; DOI: 10.1136/gutjnl-2016-311609
The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS
J Tack, K Schumacher, G Tonini, S Scartoni, A Capriati, C A Maggi

Gut Aug 2017, 66 (8) 1403-1413; DOI: 10.1136/gutjnl-2015-310683
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panés, William J Sandborn, Stefan Schreiber, Bruce E Sands, Séverine Vermeire, Geert D'Haens, Remo Panaccione, Peter D R Higgins, Jean-Frederic Colombel, Brian G Feagan, Gary Chan, Michele Moscariello, Wenjin Wang, Wojciech Niezychowski, Amy Marren, Paul Healey, Eric Maller

Gut Jun 2017, 66 (6) 1049-1059; DOI: 10.1136/gutjnl-2016-312735
Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
Jie Yu, Xiao-ling Yu, Zhi-yu Han, Zhi-gang Cheng, Fang-yi Liu, Hong-yan Zhai, Meng-juan Mu, Yan-mei Liu, Ping Liang

Gut Jun 2017, 66 (6) 1172-1173; DOI: 10.1136/gutjnl-2016-312629
Ethics and hepatitis B cure research
Jeremy Sugarman, Peter Revill, Fabien Zoulim, Yazdan Yazdanpanah, Harry L A Janssen, Seng Gee Lim, Sharon R Lewin

Gut Mar 2017, 66 (3) 389-392; DOI: 10.1136/gutjnl-2016-313009
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues
David Y Graham

Gut Feb 2017, 66 (2) 384-386; DOI: 10.1136/gutjnl-2016-311796
Reply to the letter by Dr Graham concerning ethical and interpretation issues with vonoprazan-containing H. pylori eradication therapy
Kazunari Murakami, Yuuichi Sakurai, Madoka Shiino, Nobuo Funao, Akira Nishimura, Masahiro Asaka

Gut Feb 2017, 66 (2) 386; DOI: 10.1136/gutjnl-2016-312011
Next generation of small molecules in inflammatory bowel disease
Pablo Olivera, Silvio Danese, Laurent Peyrin-Biroulet

Gut Feb 2017, 66 (2) 199-209; DOI: 10.1136/gutjnl-2016-312912
High hospital research participation and improved colorectal cancer survival outcomes: a population-based study
Amy Downing, Eva JA Morris, Neil Corrigan, David Sebag-Montefiore, Paul J Finan, James D Thomas, Michael Chapman, Russell Hamilton, Helen Campbell, David Cameron, Richard Kaplan, Mahesh Parmar, Richard Stephens, Matt Seymour, Walter Gregory, Peter Selby

Gut Jan 2017, 66 (1) 89-96; DOI: 10.1136/gutjnl-2015-311308

Main menu

clinical trials

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

clinical trials

Pages